We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Combining Tests Leads to Better Prediabetes Detection

By LabMedica International staff writers
Posted on 16 Dec 2015
The application of a screening test that is both robust and handy is vital for promptly ascertaining subjects with prediabetes. More...
A robust and quick prediabetes diagnostic test can reduce overall societal costs of diabetes by motivating subjects with prediabetes to seek diabetes preventative care.

Fasting plasma glucose (FPG) and oral glucose tolerance (OGT) tests are greatly used in screening and diagnosing type 2 diabetes and while the OGT test is mostly recognized as the benchmark for diagnosing type 2 diabetes, but the test is laborious and uncomfortable to patients.

Scientists at Georgia State University (Atlanta, GA, USA) studied a group of participants whose ages ranged from 12 to 75 years with no missing values for age, height, weight, and assayed for OGT, FPG and HbA1c. Subjects were categorized as nondiabetic if they had FPG of less than 25 mg/dL or FPG of less than 199 mg/dL on a two-hour OGT test and HbA1c less than 6.5%. Prediabetes comprises impaired fasting glucose (IFG) expressed as FPG 100–125 mg/dL, impaired glucose tolerance (IGT) as OGT of 140–199 mg/dL, and HbA1c 5.7–6.4%.

The scientists found that the joint use of FPG and HbA1c test was associated with significantly higher proportion of subjects with prediabetes across age, race/ethnicity and BMI as compared to combined use of OGT and FPG, OGT and HbA1c. Overall prevalence of prediabetes using OGT + FPG, OGT + HbA1c, HbA1c + FPG, and OGT + FPG + HbA1c tests were 20.3%, 24.2%, 33%, and 34.3%, respectively. The study indicates prediabetes rates were higher using HbA1c + FPG tests compared to the traditionally used OGT + FPG tests.

The authors concluded that using a combination of HbA1c and FPG test in screening for prediabetes provides the benefits of individual test and decreases the risk of systematic bias inherent in using only HbA1c testing. This study proposes the need to redefine a basic and a practical way on the application of HbA1cin screening for prediabetes. The use of HbA1c test in detection of prediabetes in population and clinical settings should take into account patient race/ethnicity, gender, age, and body mass index (BMI). The study was published November 20, 2015, in the journal Frontiers in Public Health.

Related Links:

Georgia State University 



Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
Portable Electronic Pipette
Mini 96
Hemodynamic System Monitor
OptoMonitor
Gold Member
Immunochromatographic Assay
CRYPTO Cassette
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New evidence shows viscoelastic testing can improve assessment of blood clotting during postpartum hemorrhage (Photo courtesy of 123RF)

Viscoelastic Testing Could Improve Treatment of Maternal Hemorrhage

Postpartum hemorrhage, severe bleeding after childbirth, remains one of the leading causes of maternal mortality worldwide, yet many of these deaths are preventable. Standard care can be hindered by delays... Read more

Immunology

view channel
Image: The CloneSeq-SV approach can allow researchers to study how cells within high-grade serous ovarian cancer change over time (Photo courtesy of MSK)

Blood Test Tracks Treatment Resistance in High-Grade Serous Ovarian Cancer

High-grade serous ovarian cancer (HGSOC) is often diagnosed at an advanced stage because it spreads microscopically throughout the abdomen, and although initial surgery and chemotherapy can work, most... Read more

Pathology

view channel
Image: The new system allows surgeons to identify genotyping of brain tumors and determine optimal resection margins during surgery (Photo courtesy of Nagoya University)

New Technique Detects Genetic Mutations in Brain Tumors During Surgery within 25 Minutes

Determining the genetic profile of brain tumors during surgery is crucial for improving patient outcomes, but conventional analysis methods can take up to two days, delaying critical decisions.... Read more

Industry

view channel
Image: The collaboration aims to improve access to Hb variant testing with the Gazelle POC diagnostic platform (Photo courtesy of Hemex Health)

Terumo BCT and Hemex Health Collaborate to Improve Access to Testing for Hemoglobin Disorders

Millions of people worldwide living with sickle cell disease and other hemoglobin disorders experience delayed diagnosis and limited access to effective care, particularly in regions where testing is scarce.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.